Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic assessment of pain and negative emotion during cognitive behavior therapy for chronic pain using ecological momentary assessment.

The journal of pain·2026
Same author

Dual-ligand curcin-loaded hybrid solid lipid nanoparticles achieve durable gliosarcoma remission while preserving neuro-behavioral function.

Theranostics·2026
Same author

Protocol to generate immunocompetent human heart-macrophage assembloids for the study of immune-cardiac interactions.

STAR protocols·2026
Same author

Brain structural correlates of individual differences in heartbeat counting and discrimination: A voxel-based morphometry study.

Scientific reports·2026
Same author

Gene-specific reversal of carbapenem-resistant Pseudomonas aeruginosa via phage-delivered CRISPR-Cas13a.

npj antimicrobials and resistance·2025
Same author

Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modeling.

Cell stem cell·2025

Related Experiment Video

Updated: Dec 25, 2025

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.0K

Direct Cardiac Reprogramming with Engineered miRNA Scaffolds.

Priyadharshni Muniyandi1, Toru Maekawa1,2, Tatsuro Hanajiri1,2

  • 1Graduate School of Interdisciplinary New Science, Toyo University, Kawagoe, Saitama, 350-8585, Japan.

Current Pharmaceutical Design
|March 29, 2020
PubMed
Summary

Directly reprogramming heart cells offers a promising therapy for heart failure. Nanoscale approaches using biomaterials for microRNA delivery can improve cardiac regeneration and overcome current limitations.

Keywords:
Direct reprogrammingcardiac tissue engineeringmiRNAmiRNA deliverymyofibroblastsscaffolds

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.6K
In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.7K

Related Experiment Videos

Last Updated: Dec 25, 2025

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.0K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.6K
In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.7K

Area of Science:

  • Cardiovascular Regenerative Medicine
  • Biomaterials Science
  • Molecular Cardiology

Background:

  • Ischemic heart disease leads to cardiomyocyte death and cardiac dysfunction.
  • Current therapies for heart failure are limited, highlighting the need for myocardial regeneration.
  • Fibroblast-to-cardiomyocyte reprogramming is a key strategy in cardiovascular regenerative medicine.

Purpose of the Study:

  • To review state-of-the-art techniques in direct cardiac reprogramming.
  • To discuss challenges and prospects of biomaterials in miRNA delivery for cardiac regeneration.
  • To explore nanoscale approaches for effective cell fate regulation.

Main Methods:

  • Review of scientific literature from 2008-2019 on cardiac regeneration.
  • Analysis of reprogramming strategies including small molecules, genetic, and epigenetic regulators.
  • Evaluation of biomaterial applications in microRNA delivery systems.

Main Results:

  • Direct reprogramming of fibroblasts to cardiomyocytes shows potential but faces challenges.
  • Biomaterials offer promising avenues for targeted microRNA delivery.
  • Nanoscale approaches are crucial for efficient and safe cardiac regeneration.

Conclusions:

  • Effective cardiac regeneration requires overcoming limitations in current reprogramming strategies.
  • Biomaterials and nanoscale engineering are vital for advancing cardiovascular regenerative medicine.
  • Future research should focus on safe and efficient delivery systems for therapeutic interventions.